Scarica l'app Stockscreener
6.38
7.77%
0.46
Pre-mercato:
6.42
0.04
+0.63%
Intensity Therapeutics Inc Borsa (INTS) Ultime notizie
US Market Recap: Does Intensity Therapeutics Inc have strong EBITDA margins2026 Sector Moves & Verified Momentum Watchlists - baoquankhu1.vn
Intensity Therapeutics receives new US patent for cancer treatment By Investing.com - Investing.com Australia
Intensity Therapeutics issued new patent in the US - TipRanks
Intensity Therapeutics receives new US patent for cancer treatment - Investing.com
Intensity Therapeutics Strengthens IP Portfolio with Issuance of New Patent in the US - ChartMill
Intensity Therapeutics Inc increases ATM offering capacity to $60 million on March 23, 2026SEC filing - marketscreener.com
Intensity Therapeutics IncIncreases ATM Offering Capacity To $60 Million On March 23, 2026SEC Filing - TradingView
Intensity Therapeutics Expands ATM Equity Offering Capacity - TipRanks
Intensity Therapeutics boosts ATM capacity to $60.0M to enhance financing flexibility - TradingView
Intensity Therapeutics (NASDAQ: INTS) boosts $60M at-the-market capacity - Stock Titan
Intensity Therapeutics (NASDAQ: INTS) raises ATM capacity to $60M - Stock Titan
If You Invested $1,000 in INTENSITY THERAPEUTICS INC (INTS) - Stock Titan
Is Intensity Therapeutics Inc currently under institutional pressure2026 Trends & High Win Rate Trade Tips - baoquankhu1.vn
Block Trades: Is Intensity Therapeutics Inc currently under institutional pressureWeekly Market Outlook & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Technical Analysis: Is Intensity Therapeutics Inc stock a top performer YTD2026 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
Aug Rallies: Should I set a stop loss on Intensity Therapeutics Inc2026 Rallies & Daily Risk Controlled Trade Plans - baoquankhu1.vn
INTS Stock Price, Quote & Chart | INTENSITY THERAPEUTICS INC (NASDAQ:INTS) - ChartMill
Forecast Cut: Can Intensity Therapeutics Inc ride the EV waveWeekly Profit Analysis & Technical Entry and Exit Alerts - baoquankhu1.vn
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement - MSN
Intensity Therapeutics reports early trial data in breast cancer - Investing.com Nigeria
Intensity Therapeutics updates breast cancer trial, files to resume enrollment following study pause - MSN
Intensity Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Nigeria
Alliance Global Partners Sticks to Their Buy Rating for Intensity Therapeutics, Inc. (INTS) - The Globe and Mail
Intensity Therapeutics Inc (INTS) Stock Price, Quote, News & History - Benzinga
Intensity Therapeutics price target adjusted to $30 at Alliance Global - TipRanks
Intensity Therapeutics Updates Breast Cancer Trial, Files To Resume Enrollment Following Study Pause - Sahm
Intensity Therapeutics reports early trial data in breast cancer By Investing.com - Investing.com Australia
Intensity Therapeutics provides update on INVINCIBLE-4 Study - TipRanks
Ballard Reports Q4 2025 and Full Year Results - Weekly Voice
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study - ChartMill
Bear Alert: Is Intensity Therapeutics Inc likely to announce a buyback2026 Intraday Action & Growth Focused Investment Plans - baoquankhu1.vn
Take Profit: Should I set a stop loss on Intensity Therapeutics Inc2026 Outlook & Safe Entry Point Identification - baoquankhu1.vn
INTS SEC FilingsINTENSITY THERAPEUTICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Intensity Therapeutics Regains Nasdaq Compliance, Stabilizing Market Listing - The Globe and Mail
Investment Review: Can Intensity Therapeutics Inc disrupt its industryQuarterly Earnings Report & Daily Oversold Bounce Ideas - baoquankhu1.vn
What's going on with Intensity Therapeutics stock Friday? - MSN
CT biotech firm regains Nasdaq compliance after carrying out reverse-stock split - Hartford Business Journal
Intensity Therapeutics Regains Nasdaq $1.00 Minimum Bid Price Compliance - TradingView
Intensity Therapeutics regains Nasdaq compliance - TipRanks
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement - PR Newswire
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Why Did INTS Stock Plummet 25% Today? - Stocktwits
INTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Intensity Therapeutics Announces Reverse Stock Split - 富途牛牛
Swing Trade: Whats next for Intensity Therapeutics Inc stockPortfolio Return Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Retail Trends: Is Intensity Therapeutics Inc stock influenced by commodity pricesJuly 2025 Setups & Daily Profit Focused Screening - baoquankhu1.vn
INTS.O Technical Analysis & Stock Price Forecast - Intellectia AI
VTVT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS Should I Buy - Intellectia AI
INTS.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
INTS.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
INTS.O PE Ratio & Valuation, Is INTS.O Overvalued - Intellectia AI
Intensity Therapeutics (INTS) Price Target Increased by 2,399.98% to 74.38 - Nasdaq
Surprises Report: Whats next for Intensity Therapeutics Inc stock2025 Retail Activity & Free Community Consensus Stock Picks - baoquankhu1.vn
Aug Mood: Is Intensity Therapeutics Inc stock forming a cup and handleJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Buy Signal: Should I set a stop loss on Intensity Therapeutics IncJuly 2025 Earnings & Accurate Buy Signal Alerts - baoquankhu1.vn
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):